azimilide
Small moleculeexperimental
Clinical trial activity
8 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
7
Phase 3
6
Phase 4
0
Earliest trial started Sep 1, 2000 (NCT00035477)
Timeline
Indications
Mechanism of action
- HERGINHIBITOR
KCNH2 inhibitor
Voltage-gated potassium channel, IKs; KCNQ1(Kv7.1)/KCNE1(MinK) inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
CN1CCN(CCCCN2C(=O)CN(/N=C/c3ccc(-c4ccc(Cl)cc4)o3)C2=O)CC1.Cl.Cl- Mol. weight
- 530.88 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3140370 ↗
- ChEMBLCHEMBL537847 ↗
- ChEMBLCHEMBL123558 ↗
Also known as
- 1-(((5-(4-chlorophenyl)-2-furanyl)methylene)amino)-3-(4-(4-methyl-1-piperazinyl)butyl)-2,4-imidazolidinedione dihydrochloride
- 2,4-imidazolidinedione, 1-(((5-(4-chlorophenyl)-2-furanyl)methylene)amino)-3-(4-(4-methyl-1-piperazinyl)butyl)-, dihydrochloride
- azimilide
- azimilide
- azimilide
- azimilide
- azimilide
- azimilide
- azimilide
- azimilide dihydrochloride
- azimilide dihydrochloride
- azimilide dihydrochloride
- azimilide dihydrochloride
- azimilide dihydrochloride
- azimilide hcl
- azimilide hydrochloride
- azimilide hydrochloride
- azimilide hydrochloride
- azimilide hydrochloride
- azimilide hydrochloride
- azmilide
- ne 10064
- ne-10064
- ne-10064
- ne-10064
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01464476 | Phase 3 | Nov 1, 2011 | Forest Laboratories |
| NCT00318838 | Phase 1 | Apr 1, 2006 | Forest Laboratories, Procter and Gamble |
| NCT00752596 | Phase 2 | Sep 1, 2005 | Forest Laboratories, Procter and Gamble |
| NCT00751738 | Phase 3 | Oct 1, 2002 | Forest Laboratories, Procter and Gamble |
| NCT00035490 | Phase 3 | Sep 1, 2001 | Forest Laboratories, Procter and Gamble |
| NCT00035451 | Phase 3 | Feb 1, 2001 | Forest Laboratories, Procter and Gamble |
| NCT00035464 | Phase 3 | Dec 1, 2000 | Forest Laboratories, Procter and Gamble |
| NCT00035477 | Phase 3 | Sep 1, 2000 | Forest Laboratories, Procter and Gamble |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Forest Laboratories | For profit | 8 | 8 | 3 | 2000 |
| Procter and Gamble | For profit | 7 | 0 | 3 | 2000 |
2 organizations
Page 1 / 1